Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RobinHood stops its account holders from buying GameStop and a few others being promoted as short squeezes by folks on Wallstreetbets. And in an “unrelated” matter, I can’t log-in to my TDAmeritrade account. The criminals are closing ranks. I hope the next thing we hear about is a class action lawsuit against RobinHood and every other brokerage that worked against their account holders by colluding to protect their hedge fund buddies.
https://www.msn.com/en-us/news/technology/robinhood-blocks-purchase-of-gamestop-amc-and-blackberry-stock/ar-BB1daXfN?ocid=uxbndlbing
And now the Charles Payne YouTube video will not play. Coincidence?
https://www.realclearpolitics.com/video/2021/01/27/charles_payne_rages_against_gamestop_shorts_all_this_whining_by_wall_street_is_making_me_sick.html
Interesting. Thanks!
Pipi said,
“...well over 100% of its outstanding shares...” How can that happen in a legitimate market? Wouldn’t there have to be naked shorting for the short interest to get over 100% of the outstanding shares?
From that article,
This was from just 10 months ago...
MXAMFUD said,
I wonder... I know from previous experience with government grants that they normally don’t allow grant money to be used to reimburse you for money you have already spent. Could it be that that is the reason there has not already been a “1st patient dosed” PR? Maybe the Biden administration has been “putting a lot of effort” into researching Brilacidin and lining up some federal funding support. If I was the new President, I would certainly want to be able to claim some credit for quickly identifying the drug that beat Covid and for speeding it through the approval process. And federal funding, along with the President’s support could certainly speed up the process enough to make up for a few days lost on the front end of our Phase 2.
Luckytouch said,
You and I usually agree. But I will have to disagree with you on this one. My analysis is as follows: Brilacidin worked very well against ABSSSI bacteria in the lab. Then it worked very well against the ABSSSI bacteria in the human body. Now we know that it worked very well against the Covid-19 virus in the lab. Since it worked against the ABSSSI bacteria in the lab and in the human body, and it worked against the virus in human tissue in the lab; I am very optimistic that Brilacidin will work against the virus in the human body. It’s possible that there is some unknown differential factor that could make it more difficult for Brilacidin to kill the virus as opposed to bacteria in the human body. But I think that is extremely unlikely. So in this upcoming Phase 2 clinical trial, I think that the chances of Brilacidin’s success are more like 90% rather than 50% as you indicate.
Here Today said,
While the Phase 1 numbers do nothing to establish efficacy, they do count toward the numbers that prove it is safe when administered via IV. So to count those numbers when talking about safety is certainly appropriate. Grumpy, you probably know but maybe some who are reading this may not know that: Most Phase 1’s only evaluate safety and they use healthy test subjects so evaluating efficacy is not part of the trial protocol.
Olden grumpini said,
Now that the Presidential politics are past, what are the chances that things move a little faster? Perhaps an IPIX PR to kick off the new President’s 1st full day?
I was aware of AstraZeneca. But I interpreted your post to say that there were 3 mRNA vaccines and I was wondering who had that 3rd one. Thank you for clarifying that.
Falcon74 said,
I am familiar with the Pfizer and Moderna vaccines, but what is the third? Thanks.
Falcon74 said,
Thanks for posting this. Did you get the Pfizer or Moderna vaccine?
“...Nobody selling...weird no?”
Kingofstink said,
I can say he is and was a lying criminal who deserves to spend the rest of his worthless life in prison.
Lemoncat said,
So much revealed in so few words...
Lemoncat said,
That one says it was created in 2012. As I recall, they started selling Anatabloc in 2010. I want to explore getting a compounding pharmacy to make some. I would like to ask everyone who has used, is using, or wants to continue using Anatabine to email me at the following address: anatabloc(at)mail.com . I set up that email account for this specific purpose. Thanks.
Does anyone know which of these is the proper chemical formulation of the Anatabine in the original version of Anatabloc? This shows 12 different versions of Anatabine.
https://pubchem.ncbi.nlm.nih.gov/#query=ANATABINE&page=1
I have read things like this which made sense to me and my admittedly limited knowledge of virucidal MOD.
StockJumper25 said,
I have read things like this which made sense to me and my admittedly limited knowledge of virucidal MOD.
StockJumper25 said,
Why?
KMBJN said,
I'm all for good results in the Covid trial and a $75-$100/share buyout in 1H2022. $4 would make me seriously disappointed. The great great grandkids too.
Lemoncat said,
That’s a true statement. It just does not apply here. Regardless of what happens with this Covid trial, IPIX still has other indications to pursue and the funding to do it with.
Crashco said,
SI agree with all of this but the last sentence. Covid is our best shot at significant gains in short term. But it is still only one bullet in the IPIX magazine. We still have multiple shots at success.
Crashco said,
I assume you mean that a BP buys Brilacidin for a price equivalent to $50 per IPIX share? We get to keep Kevetrin, right?
RFMJ said,
Any multimillion dollar governmental purchase of Brilacidin would be a game changer for IPIX. That one thing would provide an almost instantaneous financial reset for our company. I would think that the minimum price would be $1,000 per dose. (That is a LOT less than Big Pharma is currently charging for their minimally effective therapeutics.) At that $1,000 price, even 100,000 doses would bring in $100,000,000 and a million doses would bring in a billion dollars. And if Brilacidin works like we think it will, then even in the short term the governments around the world will be buying a lot more than a million doses. I think it’s going to be a VERY good year to own IPIX.
BlueFin said,
My condolences...
Kingofsting said,
If EVERYONE wore masks maybe there would be a “decrease”. Perhaps the reason that hospitals EVERYWHERE in this country have not been overwhelmed with Covid cases is because the spread of the virus has been mitigated by the people who are wearing masks. Perhaps the reason that morgues EVERYWHERE in this country have not been overwhelmed with Covid deaths is because the spread of the virus has been mitigated by the people who are wearing masks. In other words, masks may be slowing but not stopping the spread of the virus. And just maybe it is the people who are refusing to wear masks who are the reason that there is still an “increase” instead of a “decrease”.
Kingofsting said,
Interesting that you cite the “Danish study” and then mention a “war on science”. I was not aware that the “Danish study” used the “scientific method”. I don’t expect masks to be 100% effective, but I find it hard to believe that they are “useless”. Surely masks stop some exhaled moisture droplets (perhaps the larger ones?) but hey that just sounds like common sense which I know is out of favor these days.
Kingofsting said,
It could be that it’s the people who refuse to wear masks, refuse to social distance, and refuse to follow the other guidelines that are actually responsible for the “hockey stick” rise in cases. There has never been a time in my community during this Pandemic when there was not a LOT of people ignoring the guidelines. There has even been a movement in some of the churches against the government “requiring” the wearing of masks because it’s a violation of constitutional/religious freedom and many church members are refusing to wear masks as a form of protest. So I do not believe that just because the virus is spreading, you can blame that fact on the people who wear masks. I think it is probably more likely that this spreading is due to the people who are not following the guidelines. And that means the spreading would be far worse if nobody wore a mask.
Kingofsting said,
Additionally, Fox Chase has licensed Brilacidin for antifungal uses...
KarinCA said,
An “expected life cycle of 2-3 years”? You’re kidding, right?
Because doctors can prescribe Brilacidin for off-label uses; I expect that when Brilacidin is finally licensed for Covid, it will be licensed for all indications that require IV administration. That will include all bacterial indications under the ABSSSI designation, probably many other bacterial indications, hopefully Covid and related viruses, as well as numerous other (as yet untested) viruses and who knows what other diseases and conditions. I believe that Leo’s patience will result in a lucrative deal for a broad spectrum therapeutic like the world has never before seen. That’s one reason why I’m here. And that’s why I keep buying more.
As to worrying about a “large upfront” payment... I MUCH prefer a bigger cut on the back end. I’d say 50% of the gross should be about right. Of course that does not include the direct purchases that governments around the world will be making to address the Covid Pandemic. IPIX keeps 100% of that revenue.
LemonScott said,
Thanks Karin. Another excellent write-up!
Don’t forget that the FDA has granted Emergency Use Authorizations (EUA) for several drugs to try to address the Covid pandemic. If Brilacidin performs well against Covid in the upcoming trial, I expect it will also get an EUA. The federal government is also purchasing significant quantities of any approved drug that appears to work even minimally against a Covid. I expect that US purchase, and purchases by other governments around the world, will provide the funding necessary to complete any Phase 3 trials needed. The recent Merck deal (link below) for $356,000,000 ($3,560 per dose) is an example of what I’m talking about.
https://seekingalpha.com/news/3646907-merck-inks-supply-deal-for-up-to-100k-doses-of-mkminus-7110-for-covidminus-19
Cowtown said,
Merry Christmas to all! As well as a happy & prosperous New Year to all longs!
Many of us here feel that the same naked shorting crap has been going on here. Was your subpoena power granted by a federal or state court? What state or district? Please hang around! We will want to call upon your experience.
Cowtown says,
?? Brilacidin has not yet been in a Phase 3 trial, so I guess that means it could not have “failed” a Phase 3.
@Scott - This is a completely false statement. Those indications haven’t been licensed YET, but that does not mean that they are “economically unfeasible“.
Lemoncat said,
@Justfactsmam - Well done!
There is a deal with AlfaSigma, but it was the first “deal” so you would expect that it would have a lower overall value proposition. I applaud Leo for selecting UP for the first deal because it has the lowest long term revenue potential. The reason that there have been no other “deals” so far, is that Leo is too smart to be taken in by the low ball offers coming from Big Pharma. And that’s one reason I have stayed with this company through it all. I know that Leo can be depended on to hold out for something at least close to full value. Thank God for Leo! Go IPIX!
Lemoncat said,
“several hundred thousand dollars...”? ROTFLMAO!!!
Lemoncat said,
Mellalta Meets does Business Partner Identification.
Mellalta Meets specializes in identifying business partners and helps maximize the effectiveness and results of licensing strategies.
We help you in:
Technology or Drug Licensing (In-Out-Licensing)
Collaborations for R&D or Commercialization
CDMO/CMO identification for your Clinical/Pre-clinical needs
Targets Searches & Acquisitions
VC Partner for your Funding & Investment needs
https://mellalta.com/service/customs-clearance/